Efficacy of a Topical Wound Agent Methanesulfonic Acid and Dimethylsulfoxide on In Vitro Biofilms

Int J Mol Sci. 2021 Aug 31;22(17):9471. doi: 10.3390/ijms22179471.

Abstract

A topical desiccating wound agent containing methanesulfonic acid, dimethylsulfoxide and amorphous silica was evaluated in three in vitro models for its efficacy against biofilms produced by Pseudomonas aeruginosa (ATCC-15442) and Staphylococcus aureus (ATCC-6538). The in vitro biofilm models used were; the MBEC Assay®, Centre for Disease Control (CDC) Biofilm Reactor® and a Semi-solid biofilm model. A 30-s exposure of a topical wound desiccating agent was used in each model. A complete eradication of viable cells was demonstrated in all models for both strains (p < 0.0001). Imaging with scanning electron microscopy (SEM) was performed where possible. All three models demonstrated complete eradication of viable cells with a 30 s application of a topical wound desiccating agent.

Keywords: biofilm; chronic wound; debrichem; in vitro; metanesulfonic acid.

MeSH terms

  • Administration, Topical
  • Biofilms / drug effects*
  • Dimethyl Sulfoxide / metabolism
  • Dimethyl Sulfoxide / pharmacology*
  • Mesylates / metabolism
  • Mesylates / pharmacology*
  • Pseudomonas Infections / drug therapy
  • Pseudomonas aeruginosa / drug effects
  • Pseudomonas aeruginosa / pathogenicity
  • Staphylococcal Infections / drug therapy
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / pathogenicity
  • Wound Healing / drug effects
  • Wound Infection / drug therapy

Substances

  • Mesylates
  • methanesulfonic acid
  • Dimethyl Sulfoxide

Grants and funding